TFX · earnings call history
Teleflex Q2 FY26 — Strong Vascular & Surgical Performance Amidst Interventional Integration Challenges
Read the briefTeleflex Q1 FY26 — Portfolio Optimization and Capital Allocation Progress
Read the briefTeleflex Q4 FY25 — Strategic Divestitures and Future Growth Focus
Read the briefBrowse all US companies on the earnings-call register.